• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression.BRD4磷酸化调控人乳头瘤病毒E2介导的病毒转录、起始复制及细胞基质金属蛋白酶-9表达。
Cell Rep. 2016 Aug 9;16(6):1733-1748. doi: 10.1016/j.celrep.2016.07.001. Epub 2016 Jul 28.
2
Involvement of Brd4 in different steps of the papillomavirus life cycle.Brd4参与乳头瘤病毒生命周期的不同阶段。
Virus Res. 2017 Mar 2;231:76-82. doi: 10.1016/j.virusres.2016.12.006. Epub 2016 Dec 10.
3
Phosphorylation of a Conserved Tyrosine in the Papillomavirus E2 Protein Regulates Brd4 Binding and Viral Replication.乳头瘤病毒 E2 蛋白中保守酪氨酸的磷酸化调节 Brd4 结合和病毒复制。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.01801-18. Print 2019 May 15.
4
Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.乳头瘤病毒 E2 蛋白对 Brd4 阳性转录延伸因子 B 复合物的废除有助于病毒癌基因的抑制。
J Virol. 2010 Jan;84(1):76-87. doi: 10.1128/JVI.01647-09.
5
IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors.靶向 IDR 的化合物通过破坏磷酸化 BRD4 与 DNA 损伤反应因子的结合来抑制 HPV 基因组复制。
Mol Cell. 2024 Jan 18;84(2):202-220.e15. doi: 10.1016/j.molcel.2023.11.022. Epub 2023 Dec 15.
6
Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA.Brd4 蛋白被招募到人类乳头瘤病毒 16 型 DNA 复制复合物中对于病毒 DNA 的复制是必需的。
J Virol. 2013 Apr;87(7):3871-84. doi: 10.1128/JVI.03068-12. Epub 2013 Jan 30.
7
[Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].转录因子AP1在人乳头瘤病毒组织特异性调控中的可能作用
Rev Invest Clin. 2002 May-Jun;54(3):231-42.
8
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.含双溴结构域的染色质衔接蛋白Brd4与转录调控
J Biol Chem. 2007 May 4;282(18):13141-5. doi: 10.1074/jbc.R700001200. Epub 2007 Feb 28.
9
Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.乳头瘤病毒E2蛋白的不依赖Brd4的转录抑制功能。
J Virol. 2007 Sep;81(18):9612-22. doi: 10.1128/JVI.00447-07. Epub 2007 Jul 11.
10
Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.随着人乳头瘤病毒(HPV)复制工厂的扩展和病毒DNA的扩增,溴结构域蛋白4(Brd4)会从这些复制工厂中被置换出来。
PLoS Pathog. 2013;9(11):e1003777. doi: 10.1371/journal.ppat.1003777. Epub 2013 Nov 21.

引用本文的文献

1
Targeting papillomavirus infections: high-throughput screening reveals an effective inhibitor of cutaneous β-HPV types.靶向乳头瘤病毒感染:高通量筛选揭示了一种有效的皮肤β型人乳头瘤病毒抑制剂。
J Virol. 2025 Aug 19;99(8):e0091825. doi: 10.1128/jvi.00918-25. Epub 2025 Jul 8.
2
BRD4 regulates mA of ESPL1 mRNA interaction with ALKBH5 to modulate breast cancer progression.BRD4通过调控ESPL1 mRNA的m⁶A修饰以及与ALKBH5的相互作用来调节乳腺癌进展。
Acta Pharm Sin B. 2025 Mar;15(3):1552-1570. doi: 10.1016/j.apsb.2024.12.037. Epub 2025 Jan 3.
3
A Minireview on BET Inhibitors: Beyond Bromodomain Targeting.BET抑制剂综述:超越溴结构域靶向作用
Biomedicines. 2025 Mar 1;13(3):594. doi: 10.3390/biomedicines13030594.
4
An updated patent review of BRD4 degraders.BRD4 降解剂的最新专利审查
Expert Opin Ther Pat. 2024 Oct;34(10):929-951. doi: 10.1080/13543776.2024.2400166. Epub 2024 Sep 4.
5
A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer.溴结构域和末端结构域表观遗传阅读器蛋白综述:在病毒感染和癌症中的功能。
Viruses. 2024 Jul 8;16(7):1096. doi: 10.3390/v16071096.
6
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis.过表达 PLK1 通过在有丝分裂中触发 BRD4 磷酸化依赖性降解来克服前列腺癌中的 BETi 耐药性。
Cell Rep. 2024 Jul 23;43(7):114431. doi: 10.1016/j.celrep.2024.114431. Epub 2024 Jul 4.
7
The role of NF-κB in carcinogenesis of cervical cancer: opportunities and challenges.NF-κB 在宫颈癌发生中的作用:机遇与挑战。
Mol Biol Rep. 2024 Apr 20;51(1):538. doi: 10.1007/s11033-024-09447-z.
8
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells.新型BRD4-p53抑制剂SDU-071抑制MDA-MB-231三阴性乳腺癌细胞的增殖和迁移。
ACS Pharmacol Transl Sci. 2024 Mar 12;7(4):1178-1190. doi: 10.1021/acsptsci.4c00057. eCollection 2024 Apr 12.
9
Inhibition of CK2 Diminishes Fibrotic Scar Formation and Improves Outcomes After Ischemic Stroke via Reducing BRD4 Phosphorylation.抑制 CK2 可减少缺血性脑卒中后的纤维瘢痕形成,并通过降低 BRD4 磷酸化改善预后。
Neurochem Res. 2024 May;49(5):1254-1267. doi: 10.1007/s11064-024-04112-0. Epub 2024 Feb 21.
10
IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors.靶向 IDR 的化合物通过破坏磷酸化 BRD4 与 DNA 损伤反应因子的结合来抑制 HPV 基因组复制。
Mol Cell. 2024 Jan 18;84(2):202-220.e15. doi: 10.1016/j.molcel.2023.11.022. Epub 2023 Dec 15.

本文引用的文献

1
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.三阴性乳腺癌对BET溴结构域抑制剂的反应与耐药性
Nature. 2016 Jan 21;529(7586):413-417. doi: 10.1038/nature16508. Epub 2016 Jan 6.
2
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.转录可塑性促进对BET抑制的原发性和获得性耐药。
Nature. 2015 Sep 24;525(7570):543-547. doi: 10.1038/nature14898. Epub 2015 Sep 14.
3
BET inhibitor resistance emerges from leukaemia stem cells.白血病干细胞产生对BET抑制剂的耐药性。
Nature. 2015 Sep 24;525(7570):538-42. doi: 10.1038/nature14888. Epub 2015 Sep 14.
4
BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice.BET蛋白Brd4激活神经元中的转录,而BET抑制剂Jq1阻断小鼠的记忆。
Nat Neurosci. 2015 Oct;18(10):1464-73. doi: 10.1038/nn.4095. Epub 2015 Aug 24.
5
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.BET溴结构域抑制可抑制急性髓系白血病中造血转录因子的功能。
Mol Cell. 2015 Jun 18;58(6):1028-39. doi: 10.1016/j.molcel.2015.04.011. Epub 2015 May 14.
6
The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression.BET 家族成员 BRD4 与 OCT4 相互作用,调节多能性基因表达。
Stem Cell Reports. 2015 Mar 10;4(3):390-403. doi: 10.1016/j.stemcr.2015.01.012. Epub 2015 Feb 12.
7
Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition.体内诱导性沉默Brd4可确定持续抑制BET蛋白的潜在毒性。
Cell Rep. 2014 Sep 25;8(6):1919-1929. doi: 10.1016/j.celrep.2014.08.025. Epub 2014 Sep 18.
8
Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decision.在少突胶质细胞命运决定中对靶向溴结构域的BET抑制剂的非等效反应。
Chem Biol. 2014 Jul 17;21(7):804-6. doi: 10.1016/j.chembiol.2014.07.003.
9
The papillomavirus E2 proteins.乳头状瘤病毒 E2 蛋白。
Virology. 2013 Oct;445(1-2):57-79. doi: 10.1016/j.virol.2013.06.006. Epub 2013 Jul 10.
10
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.溴结构域蛋白 Brd4 使染色质免受 DNA 损伤信号的影响。
Nature. 2013 Jun 13;498(7453):246-50. doi: 10.1038/nature12147. Epub 2013 Jun 2.

BRD4磷酸化调控人乳头瘤病毒E2介导的病毒转录、起始复制及细胞基质金属蛋白酶-9表达。

BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression.

作者信息

Wu Shwu-Yuan, Nin Dawn Sijin, Lee A-Young, Simanski Scott, Kodadek Thomas, Chiang Cheng-Ming

机构信息

Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

出版信息

Cell Rep. 2016 Aug 9;16(6):1733-1748. doi: 10.1016/j.celrep.2016.07.001. Epub 2016 Jul 28.

DOI:10.1016/j.celrep.2016.07.001
PMID:27477287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4981545/
Abstract

Post-translational modification can modulate protein conformation and alter binding partner recruitment within gene regulatory regions. Here, we report that bromodomain-containing protein 4 (BRD4), a transcription co-factor and chromatin regulator, uses a phosphorylation-induced switch mechanism to recruit E2 protein encoded by cancer-associated human papillomavirus (HPV) to viral early gene and cellular matrix metalloproteinase-9 (MMP-9) promoters. Enhanced MMP-9 expression, induced upon keratinocyte differentiation, occurs via BRD4-dependent recruitment of active AP-1 and NF-κB to their target sequences. This is triggered by replacement of AP-1 family members JunB and JunD by c-Jun and by re-localization of NF-κB from the cytoplasm to the nucleus. In addition, BRD4 phosphorylation is critical for E2- and origin-dependent HPV DNA replication. A class of phospho-BRD4-targeting compounds, distinct from the BET bromodomain inhibitors, effectively blocks BRD4 phosphorylation-specific functions in transcription and factor recruitment.

摘要

翻译后修饰可以调节蛋白质构象,并改变基因调控区域内结合伴侣的募集。在此,我们报告含溴结构域蛋白4(BRD4),一种转录辅因子和染色质调节剂,利用磷酸化诱导的开关机制将癌症相关人乳头瘤病毒(HPV)编码的E2蛋白募集至病毒早期基因和细胞基质金属蛋白酶9(MMP-9)启动子。角质形成细胞分化时诱导的MMP-9表达增强,是通过BRD4依赖的方式将活性AP-1和NF-κB募集至其靶序列实现的。这是由c-Jun取代AP-1家族成员JunB和JunD以及NF-κB从细胞质重新定位到细胞核所触发的。此外,BRD4磷酸化对于E2和依赖于起始点的HPV DNA复制至关重要。一类靶向磷酸化BRD4的化合物,不同于BET溴结构域抑制剂,能有效阻断BRD4磷酸化特异性的转录和因子募集功能。